Evidence map›Paper›PMID 20097770›Full record

ArticleAmerican journal of physiology. Heart and circulatory physiology2010

Effects of dietary omega-3 fatty acids on ventricular function in dogs with healed myocardial infarctions: in vivo and in vitro studies.

George E Billman, Yoshinori Nishijima, Andriy E Belevych, Dmitry Terentyev, Ying Xu, Kaylan M Haizlip, Michelle M Monasky, Nitisha Hiranandani, William S Harris, Sandor Gyorke and 2 more

Abstract read
In one paragraph

Article in American journal of physiology. Heart and circulatory physiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 40 citations in OpenAlex.

  1. Fish oil and neurovascular control in humans.American journal of physiology. Heart and circulatory physiology · 2012
    Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

George E BillmanDept. of Physiology and Cell Biology, The Ohio State Univ., Columbus, 43210-1218, USA. billman.1@osu.edu
Yoshinori Nishijima
Andriy E Belevych
Dmitry Terentyev
Ying Xu
Kaylan M Haizlip
Michelle M Monasky
Nitisha Hiranandani
William S Harris
Sandor Gyorke
Cynthia A Carnes
Paul M L Janssen
Sutter Davis Hospital · USSanford Research · US

Funding

CONTROLLED AND UNCONTROLLABLE CALCIUM RELEASE IN HEARTR01HL063043 · NHLBI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI Sandor Gyorke · 1999 to 2026
$8.6M
Ryanodine Receptor Channels in Heart FailureR01HL074045 · NHLBI · TEXAS TECH UNIVERSITY HEALTH SCIS CENTER · PI GYORKE, SANDOR · 2003 to 2024
$8.2M
Heart Failure and Atrial FibrillationR01HL089836 · NHLBI · OHIO STATE UNIVERSITY · PI CARNES, CYNTHIA A · 2008 to 2012
$2.1M
Dietary Omega-3 Fatty Acids and Sudden Cardiac DeathR01HL086700 · NHLBI · OHIO STATE UNIVERSITY · PI BILLMAN, GEORGE EDWARD · 2007 to 2010
$1.9M
NHLBI NIH HHS HL-063043NHLBI NIH HHS HL-074045NHLBI NIH HHS HL-086700NHLBI NIH HHS HL-089836
6 · The paper itself

Abstract

Since omega-3 polyunsaturated fatty acids (n-3 PUFAs) can alter ventricular myocyte calcium handling, these fatty acids could adversely affect cardiac contractile function, particularly following myocardial infarction. Therefore, 4 wk after myocardial infarction, dogs were randomly assigned to either placebo (corn oil, 1 g/day, n = 16) or n-3 PUFAs supplement [docosahexaenoic acid (DHA) + eicosapentaenoic acid (EPA) ethyl esters; 1, 2, or 4 g/day; n = 7, 8, and 12, respectively] groups. In vivo, ventricular function was evaluated by echocardiography before and after 3 mo of treatment. At the end of the 3-mo period, hearts were removed and in vitro function was evaluated using right ventricular trabeculae and isolated left ventricular myocytes. The treatment elicited significant (P < 0.0001) dose-dependent increases (16.4-fold increase with 4 g/day) in left ventricular tissue and red blood cell n-3 PUFA levels (EPA + DHA, placebo, 0.42 +/- 0.04; 1 g/day, 3.02 +/- 0.23; 2 g/day, 3.63 +/- 0.17; and 4 g/day, 6.97 +/- 0.33%). Regardless of the dose, n-3 PUFA treatment did not alter ventricular function in the intact animal (e.g., 4 g/day, fractional shortening: pre, 42.9 +/- 1.6 vs. post, 40.1 +/- 1.7%; placebo: pre, 39.2 +/- 1.3 vs. post, 38.4 +/- 1.6%). The developed force per cross-sectional area, changes in length- and frequency-dependent behavior in contractile force, and the inotropic response to beta-adrenoceptor activation were also similar for trabeculae obtained from placebo- or n-3 PUFA-treated dogs. Finally, calcium currents and calcium transients were the same in myocytes from n-3 PUFA- and placebo-treated dogs. Thus dietary n-3 PUFAs did not adversely alter either in vitro or in vivo ventricular contractile function in dogs with healed infarctions.

Indexed as

AnimalsCalciumDietary SupplementsDisease Models, AnimalDocosahexaenoic AcidsDogsDose-Response Relationship, DrugEicosapentaenoic AcidFatty AcidsFatty Acids, Omega-3FemaleHeart VentriclesMaleMyocardial ContractionMyocardial InfarctionMyocardium4,7,10,13,16,19-docosahexaenoic acid ethyl esterCalciumDocosahexaenoic AcidsEicosapentaenoic Acideicosapentaenoic acid ethyl esterFatty AcidsFatty Acids, Omega-3

Identifiers

PMID20097770
PMCPMC2853418
OpenAlexW2143938609

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.